4//SEC Filing
Greenberg Bruce 4
Accession 0000950170-24-030314
CIK 0001341235other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:07 PM ET
Size
7.7 KB
Accession
0000950170-24-030314
Insider Transaction Report
Form 4
Greenberg Bruce
See Remarks
Transactions
- Sale
Common Stock
2024-03-11$3.41/sh−13,201$44,968→ 120,699 total - Award
Stock Option (right to buy)
2024-03-09+252,280→ 252,280 totalExercise: $3.62Exp: 2034-03-08→ Common Stock (252,280 underlying)
Footnotes (3)
- [F1]These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.27 to $3.58. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2024.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001928391
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 8:07 PM ET
- Size
- 7.7 KB